Viewpoints: Pros And Cons Of Biogen’s Decision To Reevaluate Alzheimer’s Drug; Isn’t It Really Time To Criminally Prosecute Companies Behind Opioid Epidemic?

Editorial writers express views on these health issues and others.

from Kaiser Health News https://ift.tt/33ZoC1a